The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2005

Filed:

Mar. 14, 2003
Applicants:

Ram Pratap, Lucknow, IN;

Ram Chandra Gupta, Lucknow, IN;

Ramesh Chander, Lucknow, IN;

Ashok Kumar Khanna, Lucknow, IN;

Arvind Kumar Srivastava, Lucknow, IN;

Deepak Raina, Lucknow, IN;

Satyavan Singh, Lucknow, IN;

Savita Srivastava, Lucknow, IN;

Anil Kumar Rastogi, Lucknow, IN;

Omkar Prasad Asthana, Lucknow, IN;

Swarn Nityanand, Lucknow, IN;

Nitya Anand, Lucknow, IN;

Ashim Ghatak, Lucknow, IN;

Narinder Kumar Kapoor, Lucknow, IN;

Sukh Dev, Lucknow, IN;

Inventors:

Ram Pratap, Lucknow, IN;

Ram Chandra Gupta, Lucknow, IN;

Ramesh Chander, Lucknow, IN;

Ashok Kumar Khanna, Lucknow, IN;

Arvind Kumar Srivastava, Lucknow, IN;

Deepak Raina, Lucknow, IN;

Satyavan Singh, Lucknow, IN;

Savita Srivastava, Lucknow, IN;

Anil Kumar Rastogi, Lucknow, IN;

Omkar Prasad Asthana, Lucknow, IN;

Swarn Nityanand, Lucknow, IN;

Nitya Anand, Lucknow, IN;

Ashim Ghatak, Lucknow, IN;

Narinder Kumar Kapoor, Lucknow, IN;

Sukh Dev, Lucknow, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K031/56 ; A61K031/59 ;
U.S. Cl.
CPC ...
Abstract

The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I) as shown herein belowWherein X═OH or O or combination thereof and positioning of olefinic bonds are at 4(5); 5(6); 16(17); 17(20) or various combinations and said compounds containing at least one olefinic bond in or on their D-ring for the treatment of hyperlipidemic and hyperglycemic conditions in mammals, said method comprising administering an effective amount of the said compounds to the recipient mammals.


Find Patent Forward Citations

Loading…